Bragar Eagel & Squire Urges Picard Medical Investors to Contact Firm Before April 3rd

Law firm announces class action lawsuit against Picard Medical over alleged stock promotion scheme.

Mar. 16, 2026 at 1:48am

Got story updates? Submit your updates here. ›

Bragar Eagel & Squire, P.C., a national stockholder rights law firm, has filed a class action lawsuit against Picard Medical, Inc. (NYSE:PMI) in the U.S. District Court for the Northern District of California on behalf of investors who purchased Picard securities between September 2, 2025, and October 31, 2025. The lawsuit alleges that Picard failed to disclose a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals, as well as insider trading and artificial price inflation.

Why it matters

The lawsuit against Picard Medical highlights growing concerns around stock promotion schemes and the need for greater transparency and accountability in the financial markets. Investors who suffered losses may be able to recover damages through the class action lawsuit.

The details

According to the complaint, Picard was the subject of a fraudulent stock promotion scheme that involved the use of social media-based misinformation and impersonated financial professionals to inflate the company's stock price. The lawsuit also alleges that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during the price inflation campaign. Picard's public statements and risk disclosures allegedly omitted any mention of the false rumors and artificial trading activity driving the stock price.

  • The class period for the lawsuit is September 2, 2025, to October 31, 2025.
  • On October 24, 2025, Picard's stock price abruptly crashed 70%, to $3.99 per share.
  • Since the October 24, 2025 crash, Picard's share price has continued to decline to approximately $2.00 per share.

The players

Bragar Eagel & Squire, P.C.

A nationally recognized stockholder rights law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities, derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation.

Picard Medical, Inc.

A publicly traded medical device company listed on the New York Stock Exchange under the ticker symbol PMI.

Brandon Walker

A litigation partner at Bragar Eagel & Squire, P.C. who is encouraging investors who suffered losses in Picard (PMI) to contact him directly to discuss their options.

Melissa Fortunato

A partner at Bragar Eagel & Squire, P.C. who is encouraging investors who suffered losses in Picard (PMI) to contact her directly to discuss their options.

Got photos? Submit your photos here. ›

What they’re saying

“If you purchased or acquired Picard securities between September 2, 2025, and October 31, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648.”

— Brandon Walker, Litigation Partner, Bragar Eagel & Squire, P.C.

What’s next

Investors have until April 3, 2026 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The takeaway

The lawsuit against Picard Medical highlights the need for greater transparency and accountability in the financial markets, as well as the importance of investor protections against fraudulent stock promotion schemes. Investors who suffered losses may be able to recover damages through the class action lawsuit.